NPS MedicineWise responds to the Review of NPS MedicineWise Quality Use of Medicines Funding Decision
This statement relates to the independent review of the 2022-23 Budget Measure Guaranteeing Medicare and Access to Medicines – Improving Access to Medical Equipment, Treatment and Diagnostic undertaken by Dr Pradeep Philip at Deloitte Access Economics and the subsequent report (the Report). This Report was published on September 15, 2022.
NPS MedicineWise response:
NPS MedicineWise accepts the decision of the Minister in response to the Report and will make every effort to ensure a positive transition of activities for the benefit of the Australian people. The company is very proud of its work and will ensure that an accurate record is provided to support future QUM initiatives. This response provides further information to correct and explain some parts of the Report.
While the analysis and recommendations in the Report are largely sound, it has been selective in its use of facts and the conclusion is largely unsubstantiated. The conclusion has had a catastrophic impact on NPS MedicineWise (see this media release).
NPS MedicineWise does not agree with a number of the observations of the Report and had requested that inaccuracies/misrepresentations be corrected prior to publication. This request was declined.
Report inaccuracies
The Report contains several inaccuracies and/or misrepresentations. Specifically: